Journal ArticleSleep · November 2010
STUDY OBJECTIVES: using a comprehensive cognitive-behavioral model of insomnia and a daily process approach, this study was conducted to examine the contribution of cancer symptoms and dysfunctional sleep related thoughts and behaviors to the process of in ...
Full textLink to itemCite
Journal ArticleBreast Cancer Res Treat · February 2010
The purpose of this study was to determine the safety and maximum tolerated dose (MTD) of BZL101 (FDA IND# 59,521), an orally delivered aqueous extract from the herb Scutellaria barbata, in women with metastatic breast cancer (MBC). The trial was an open-l ...
Full textLink to itemCite
Journal ArticleJ Pain Symptom Manage · June 2009
Programmed, notebook-style, personal computers ("e/Tablets") can collect symptom and quality-of-life (QOL) data at the point of care. Patients use an e/Tablet in the clinic waiting area to complete electronic surveys. Information then travels wirelessly to ...
Full textLink to itemCite
Journal ArticleJ Support Oncol · 2009
Notebook-style computers (e/Tablets) are increasingly replacing paper methods for collecting patient-reported information. Discrepancies in data between these methods have been found in oncology for sexuality-related questions. A study was performed to for ...
Link to itemCite
Journal ArticleHealth Serv Res · December 2008
OBJECTIVE: To determine whether e/Tablets (wireless tablet computers used in community oncology clinics to collect review of systems information at point of care) are feasible, acceptable, and valid for collecting research-quality data in academic oncology ...
Full textLink to itemCite
Journal ArticleOncol Nurs Forum · July 2008
PURPOSE/OBJECTIVES: To compare the effectiveness of a prescribed home-based walking exercise intervention with usual care in older women receiving hormonal treatment for breast cancer, and to examine relationships among levels of the cortisol, serotonin, i ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 20, 2008
1099 Background: BZL101 is an aqueous extract from herba Scutellaria Barbata. BZL101 demonstrates in vitro growth inhibitory effects on human breast cancer cell lines and does not inhibit the growth of normal human mammary epithelium. In a murine xenograft ...
Link to itemCite
Journal ArticleCancer Invest · 2008
BACKGROUND: Premenopausal women treated for early stage breast cancer (ESBC) are at risk for chemotherapy-related amenorrhea (CRA). Prospectively-validated, predictive markers of CRA are needed. PATIENTS AND METHODS: Premenopausal women with ESBC and plann ...
Full textLink to itemCite
Journal ArticleIntegr Cancer Ther · June 2007
Extracts of milk thistle have been recognized for centuries as "liver tonics" and are well-known to prevent or reverse hepatotoxicity of reactive drug metabolites or naturally occurring toxins. Milk thistle extracts are now under intense study in the exper ...
Full textLink to itemCite
Journal ArticleJ Pain Symptom Manage · March 2007
Metastatic breast cancer (MBC) remains a terminal illness for which major treatment advances are slow to appear, and hence it is crucial that effective palliative interventions be developed to reduce the cancer-related symptoms of women with this condition ...
Full textLink to itemCite
Journal ArticleActa Horticulturae · January 1, 2006
Botanical dietary supplements are often targeted by the mainstream media and scientific/medical communities as being unscientific and unsafe relative to prescription pharmaceuticals and over-the counter drugs. However, the relative risk of botanical medici ...
Full textCite
Journal ArticleJ Clin Oncol · November 1, 2005
PURPOSE: ABI-007, the first biologically interactive albumin-bound paclitaxel in a nanameter particle, free of solvents, was compared with polyethylated castor oil-based standard paclitaxel in patients with metastatic breast cancer (MBC). This phase III st ...
Full textLink to itemCite
Journal ArticleExpert Opin Pharmacother · May 2002
Over the last 30 years the role of tamoxifen in breast cancer treatment has been progressively expanded by clinical investigation to encompass the entire spectrum of disease from cancer chemoprevention to palliation of advanced disease. The primacy of tamo ...
Full textLink to itemCite
Journal ArticleActa Cytol · 1999
OBJECTIVE: To clarify the importance of squamous and glandular atypia in the genital tracts of women undergoing high-dose chemotherapy and receiving tamoxifen. STUDY DESIGN: The pathology records of 769 female bone marrow transplant recipients from a five- ...
Full textLink to itemCite
Journal ArticleInternational Journal of Gynecological Cancer · December 1, 1998
To elucidate further the molecular pathogenesis of cervical cancer we sought to determine whether mutations in the PTEN tumor suppressor gene are a feature of these cancers. Genomic DNA was extracted from 67 primary cervical cancers and 9 immortalized cerv ...
Full textCite
Journal ArticleGynecol Oncol · July 1998
OBJECTIVE: The PTEN tumor suppressor gene on chromosome 10q23 undergoes inactivating mutations in several types of malignancies including glioblastomas and prostate and endometrial carcinomas. The aim of this study was to determine if mutation of the PTEN ...
Full textLink to itemCite
Journal ArticleCancer Res · June 15, 1998
Mutation and deletion of the PTEN tumor suppressor gene occurs in about 40% of endometrial carcinomas. The purpose of this study was to determine whether PTEN mutations also are present in endometrial hyperplasias, which are premalignant precursors of inva ...
Link to itemCite